JMP Securities Reiterates Market Outperform on Steris, Maintains $265 Price Target
Portfolio Pulse from Benzinga Newsdesk
JMP Securities analyst David Turkaly has reiterated a Market Outperform rating on Steris (NYSE:STE) and maintained a price target of $265.
July 26, 2024 | 6:20 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
JMP Securities analyst David Turkaly has reiterated a Market Outperform rating on Steris and maintained a price target of $265.
The reiteration of a Market Outperform rating and the maintenance of a $265 price target by JMP Securities is a positive signal for investors, suggesting confidence in Steris's future performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100